Early Life Intervention in Pediatrics Supported by E-health - SMOKE

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 5
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age: younger than 6 years

Exposed to second-hand smoke at home (at least one parent smoking)

German speaking parent

All sex and ethnic backgrounds

Disqualifiers

Participation in another study/trial targeting similar outcomes

Participation in an active smoking cessation programme

Trial design

Design model

Parallel

Treatments tested in this trial

  • Life-Style app

    Behavioral

    The modules of the Life-Style app are introduced and unlocked sequentially during the first weeks of the intervention phase. Afterwards the modules are fully available. Duration and frequency of app-use is not limited. The parents are accompanied by a coach through the app, who gives regular structured feedback and individual inputs. The coach has access to all data collected in the app.

  • Sham Comparator

    Other intervention

    The parents get a flyer with information on second-hand smoke exposure and references to smoking cessation programs, and do not have an active app during the main intervention period.

Treatment groups

160 Participants
are divided into 2 treatment groups
Group A: Treatment group (Life-style app)Experimental treatment 1 intervention
Group B: Control groupSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change from baseline in urinary levels of cotinine in children

Change in exposure to second-hand smoke exposure assessed by urinary levels of cotinine

Time frame
At 22 weeks after baseline (Post intervention)
2

Change from baseline in urinary levels of cotinine in children

Change in exposure to second-hand smoke exposure assessed by urinary levels of cotinine

Time frame
At 48 weeks after baseline (Follow-Up)

Secondary outcomes

1

Change from baseline in protective measures taken by parents to protect children from second-hand smoke exposure

Parents are asked (using a questionnaire) about the measures taken to protect children from second-hand smoke exposure at baseline, during the intervention, postintervention and follow-up. Protective measures assessed include washing hands, smoking outside (including not smoking in the car), changing clothes after smoking). The questionnaire consists of five items (protective measures) with a score ranging from 1 to 5. Score 5 means a better result.

Time frame
During intervention (week 2-22), post intervention (week 22-23) and follow-up (week 48-49)

Other outcomes

1

Acceptance and usability of the app (parent reported outcome)

The usability of the app is assessed using the eHealth App Usability Questionnaire (MAUQ). The questionnaire measures usability on three subscales (ease of use, Interface and satisfaction, usefulness). The MAUQ questionnaire consists of 18 items with a score ranging from 1 to 7. Score 7 means a better result.

Time frame
At 22 weeks after baseline (Post intervention)
2

Acceptance of the app

The acceptance of the app is measured by means of dropout rate.

Time frame
During the intervention (week 2-22)
3

Usability of the app

The usability of the app is measured by means of how often and how long the parents use the app.

Time frame
During the intervention (week 2-22)
4

Number of episodes of airway disease in children

Parents are asked to report any event of airway disease (including any type of upper or lower respiratory tract infection; e.g. otitis media, rhinitis, pharyngitis, acute or chronic bronchitis, protracted bacterial bronchitis, chronic cough, pneumonia).

Time frame
Baseline, at 22 weeks (Post intervention) and at 48 weeks (Follow-Up) after baseline

Sponsors and contacts

Click on the lead sponsor to view all of their trials.